Skip to content
  • Home
  • Sectors
    • Financials
    • Healthcare
    • Materials
    • Industrials
    • Energy
    • Information Technology
    • Consumer Staples
    • Utilities
    • Consumer Discretionary
    • Uncategorised
  • News Type
    • Corporate Strategy & Guidance
    • Dividends & Share Buybacks
    • Earnings Reports
    • Industry-Specific News
    • Investor Relations
    • IPO & Public Listings
    • Macroeconomic Impact
    • Mergers & Acquisitions
    • Regulatory News & Compliance
    • Shareholder Updates
    • Stock Price Movements
  • About Us

Latest News

Donaco International Limited (ASX:DNA) Updates Scheme Timetable and Cambodian Tax Position

Black Dragon Gold Corp (ASX:BDG) Reports Q1 2025 Financial Results and Project Updates

Augustus Minerals (ASX:AUG) Acquires ACMPNG and Advances Mt Kare Gold Project License

Arika Resources Limited (ASX:ARI) Upsizes Drilling Program

VHM Limited (ASX:VHM) Announces Equity Raising and Project Update

NZME Limited (ASX:NZM) Updates Director Nominations

Wide Open Agriculture (ASX:WOA) Secures $2.6M Placement & Launches SPP

REA Group Ltd (ASX:REA) Delivers Strong Q3 Results

OpenLearning Limited (ASX:OLL) Converts Debt to Equity with ECA

Chrysos Corporation Limited (ASX:C79) Signs Master Services Agreement with Newmont Corporation

The Capital Club

The Capital Club

The Hub of Australian Finance News

  • Home
  • Sectors
    • Financials
    • Healthcare
    • Materials
    • Industrials
    • Energy
    • Information Technology
    • Consumer Staples
    • Utilities
    • Consumer Discretionary
    • Uncategorised
  • News Type
    • Corporate Strategy & Guidance
    • Dividends & Share Buybacks
    • Earnings Reports
    • Industry-Specific News
    • Investor Relations
    • IPO & Public Listings
    • Macroeconomic Impact
    • Mergers & Acquisitions
    • Regulatory News & Compliance
    • Shareholder Updates
    • Stock Price Movements
  • About Us
Friday, May 09, 2025

Category: ASX-1AI

Algorae Pharmaceuticals Limited

Algorae Pharmaceuticals (ASX:1AI) Partners with Peter MacCallum Cancer Centre for AI-Driven Drug Screening
ASX-1AI Healthcare

Algorae Pharmaceuticals (ASX:1AI) Partners with Peter MacCallum Cancer Centre for AI-Driven Drug Screening

ClubAI 8 May 2025 11:08 am

Algorae Pharmaceuticals (ASX:1AI) partners with Peter MacCallum Cancer Centre to validate AI-driven drug synergies in oncology.

Corporate Strategy & GuidanceIndustry-Specific News

Article Categories

  • Consumer Discretionary
  • Consumer Staples
  • Energy
  • Financials
  • Healthcare
  • Industrials
  • Information Technology
  • Materials
  • Real Estate
  • Telecommunication Services
  • Uncategorised
  • Utilities
  • Publishing Policy
  • About Us
  • Author Biography
The Capital Club